Resbiotic has launched a direct-to-consumer microbiome test using shotgun metagenomics sequencing, offering personalized reports on microbial diversity, gut inflammation markers, intestinal permeability, and keystone bacterial strains. The test integrates with the company's probiotic formulas, enabling consumers to track microbiome changes over 60- to 90-day intervals and adjust supplementation based on longitudinal data.
Key Points
- Shotgun metagenomics identifies diversity, inflammation, permeability, and keystone bacteria
- Results guide personalized probiotic selection aligned to individual microbiome profile
- Serial testing every 60-90 days enables tracking of intervention response over time
Longevity Analysis
The ability to decode microbial composition and function at scale—and to repeat measurement over intervals—addresses a critical gap in health optimization. Microbiome composition influences immune tolerance, metabolic endotoxemia, and intestinal barrier integrity, all of which shape chronic disease risk and aging trajectory. Direct access to this data without physician gatekeeping allows individuals to eliminate ineffective interventions and gain advantage through targeted supplementation backed by their own microbiota profile rather than population averages. The serial testing model supports the discipline of sustained protocol adjustment, treating microbiome optimization as a measurable practice rather than a one-time intervention.
Original published by LT Wire.